65.4% of hospitalized ITP inpatients did not have a bleeding episode or surgical procedure associated with their platelet transfusion. Platelet transfusions were not associated with improved clinical ...
Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up. Seventy-eight patients undergoing induction therapy for acute leukemia were randomized to receive ...
OBJECTIVE: To determine the most effective, evidence-based approach to the use of platelet transfusions in patients with cancer. OUTCOMES: Outcomes of interest included prevention of morbidity and ...
The US Food and Drug Administration (FDA) has approved avatrombopag (Doptelet, AkaRx Inc) to increase platelet counts in adults with thrombocytopenia and chronic liver disease who are to undergo a ...
A preliminary study published in this week's issue of THE LANCET suggests a possible explanation for the biological process responsible for inducing fever and related symptoms after the transfusion of ...
Myelodysplastic syndromes (MDS) can damage bone marrow, lowering red blood cells and platelets. Transfusions replace missing cells to manage anemia or thrombocytopenia. Up to 9 in 10 people with MDS ...
A similar observation was made in our laboratory in a patient with a relapse of acute lymphoblastic leukemia (ALL) (male, age 6 years). The mutation screening of the complete mtDNA revealed 19 ...
December 6, 2008 (San Francisco, California) — The dose of platelets given by transfusion to cancer patients who become thrombocytopenic can be halved without increasing the risk of bleeding, ...
This article argues for the adoption of a combined lyophilized plasma and platelet product strategy to address critical gaps.
Four people in three states developed sepsis after receiving bacteria-contaminated platelet transfusions between May and October last year, according to a US government report released Thursday. One ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results